Glaukos Profile

Performance

1414
   

Odds of Distress

Check how we calculate scores
Equity ratings for Glaukos Corporation are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting May 23, 2019 and ending today July 22, 2019. Click here to learn more.
75.83
USD 0.69  0.92%

Glaukos Summary

Glaukos Corporation (GKOS) is traded on BATS Exchange in USA. It is located in 229 Avenida Fabricante and employs 437 people. Glaukos is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.79B. Glaukos conducts business under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 36.4M outstanding shares of which 3.05M shares are currently shorted by private and institutional investors with about 8.12 trading days to cover. Glaukos Corporation Common Stoc currently holds about 145.26M in cash with 25.52M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.99.
Check Glaukos Probability Of Bankruptcy

Ownership Allocation (%)

Glaukos Target Price Odds Analysis

Odds Below 75.83HorizonTargetOdds Above 75.83
72.80%30 days 75.83 27.04%
Based on normal probability distribution, the odds of Glaukos to move above current price in 30 days from now is about 27.04% (This Glaukos Corporation probability density function shows the probability of Glaukos Stock to fall within a particular range of prices over 30 days) .

Glaukos Top Holders

Glaukos Corporation Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Glaukos Key Fundamentals

Glaukos Against Markets

Glaukos Vital Trading Data

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos Corporation was founded in 1998 and is headquartered in San Clemente, California. Glaukos operates under Medical Instruments Supplies classification in USA and is traded on BATS Exchange. It employs 437 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
Glaukos SEC Filings
Glaukos SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameGlaukos Corporation
CEO and President and DirectorThomas BurnsView All
Thematic Classification
Currently Active Investing Idea
  Medical Equipment
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Medical Instruments & Supplies
InstrumentUSA Stock View All
RegionNorth America
LocationCalifornia U.S.A
Business Address229 Avenida Fabricante
ExchangeBATS Exchange
CIK Number0001192448
CUSIP377322102
SectorHealthcare
IndustryMedical Instruments & Supplies
BenchmarkDOW
Websitewww.glaukos.com
Phone949 367 9600
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterMarch 31, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestJune 28, 2019

Glaukos Corporate Directors

Gilbert Kliman Independent Director
Jonathan Silverstein Independent Director
David Hoffmeister Independent Director
Please also check Risk vs Return Analysis. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.
Search macroaxis.com